نتائج البحث - "Jiankang Liu"

1

Outpatient diuretic intensification as endpoint in heart failure with preserved ejection fraction trials: an analysis from TOPCAT

المؤلفون: Faiez Zannad, João Pedro Ferreira, Marc A. Pfeffer, Brian Claggett, Jiankang Liu, Scott D. Solomon, Orly Vardeny, Bertram Pitt

المصدر: European Journal of Heart Failure. 24:378-384

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b6062ca19f468ae75c2b6f7b639269d
https://doi.org/10.1002/ejhf.2376

View record at Wiley

2

Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF

المؤلفون: Dirk J. van Veldhuisen, Michael R. Zile, Jean L. Rouleau, Michele Senni, Jiankang Liu, Burkert Pieske, Marc A. Pfeffer, Milton Packer, Carolyn S.P. Lam, Margaret F. Prescott, Aldo P. Maggioni, Brian Claggett, Martin Lefkowitz, Pardeep S. Jhund, John J.V. McMurray, Faiez Zannad, Mauro Gori, Scott D. Solomon, Victor Shi

المساهمون: Cardiovascular Centre (CVC)

المصدر: JACC. Heart failure, 9(9), 627-635. ELSEVIER SCI LTD

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be39ac7cb6043c1c8c365a8d1503a830
https://doi.org/10.1016/j.jchf.2021.04.009

Full Text via ClinicalKey

3

Serum potassium and outcomes in heart failure with preserved ejection fraction: a post‐hoc analysis of the PARAGON‐HF trial

المؤلفون: Michael R. Zile, Akshay S. Desai, Brian Claggett, Lars Køber, Orly Vardeny, Faiez Zannad, Martin Lefkowitz, Inder S. Anand, Victor Shi, Dirk J. van Veldhuisen, John G.F. Cleland, Milton Packer, João Pedro Ferreira, John J.V. McMurray, Marc A. Pfeffer, Sanjiv J. Shah, Scott D. Solomon, Jean L. Rouleau, Jiankang Liu

المساهمون: Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), British Heart Foundation Glasgow Cardiovascular Research Centre (BHF GCRC), University of Glasgow-NHS Greater Glasgow and Clyde, Brigham & Women’s Hospital [Boston] (BWH), Harvard Medical School [Boston] (HMS), University of Minnesota [Twin Cities] (UMN), University of Minnesota System, University Medical Center Groningen [Groningen] (UMCG), Rigshospitalet [Copenhagen], Copenhagen University Hospital, University of Glasgow, Montreal Heart Institute - Institut de Cardiologie de Montréal, Imperial College London, Baylor University, University of South California (USC), Neuroimaging group, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, Northwestern University Feinberg School of Medicine, Minneapolis VA Center for Care Delivery and Outcomes Research, University of Minnesota, J.P.F. is funded by an ESC research grant for collaboration with the University of Glasgow. All other authors report no specific funding for this project. J.J.V.McM. and P.S.J. are supported by a British Heart Foundation Centre of Research Excellence Grant RE/18/6/34217., BOZEC, Erwan, University of Southern California (USC), Novartis Pharmaceuticals Corporation [East Hanover, NJ], Cardiovascular Centre (CVC)

المصدر: Ferreira, J P, Claggett, B L, Liu, J, Desai, A S, Pfeffer, M A, Anand, I S, van Veldhuisen, D J, Kober, L, Cleland, J G F, Rouleau, J L, Packer, M, Zile, M R, Shi, V C, Lefkowitz, M P, Shah, S J, Vardeny, O, Zannad, F, Solomon, S D & McMurray, J J V 2021, ' Serum potassium and outcomes in heart failure with preserved ejection fraction : a post-hoc analysis of the PARAGON-HF trial ', European Journal of Heart Failure, vol. 23, no. 5, pp. 776-784 . https://doi.org/10.1002/ejhf.2134
European Journal of Heart Failure
European Journal of Heart Failure, Oxford University Press (OUP), 2021, ⟨10.1002/ejhf.2134⟩
European Journal of Heart Failure, 2021, ⟨10.1002/ejhf.2134⟩
European Journal of Heart Failure, 23(5), 776-784. Wiley

مصطلحات موضوعية: medicine.medical_specialty, Outcomes, 030204 cardiovascular system & hematology, valsartan, Sacubitril, Angiotensin Receptor Antagonists, 03 medical and health sciences, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Internal medicine, medicine, Humans, Sacubitril/valsartan, Aged, Cause of death, Heart Failure, Ejection fraction, business.industry, Aminobutyrates, Serum potassium, Hazard ratio, Stroke Volume, medicine.disease, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 3. Good health, Heart failure with preserved ejection fraction, Valsartan, Heart failure, Potassium, Cardiology, Female, Cardiology and Cardiovascular Medicine, business, Sacubitril, Valsartan, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a4da8e89429c383f280196584a0932a
https://doi.org/10.1002/ejhf.2134

View record at Wiley

4

The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC-HF)

المؤلفون: Tor Biering-Sørensen, John R. Teerlink, Fady I. Malik, Brian Claggett, Jason C. Legg, Christopher E. Kurtz, Narimon Honarpour, Scott D. Solomon, John J.V. McMurray, Masatoshi Minamisawa, Jiankang Liu, G. Michael Felker, Alexander Papolos

المصدر: European journal of heart failureReferences. 23(6)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc333463b67d831267b58dffff5dd8d6
https://pubmed.ncbi.nlm.nih.gov/33826209

View record at Wiley

5

Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM-HF trial

المؤلفون: Jiankang Liu, Orly Vardeny, Milton Packer, Karl Swedberg, John J.V. McMurray, Martin Lefkowitz, Brian Claggett, Muthiah Vaduganathan, Michael R. Zile, Scott D. Solomon, Akshay S. Desai, Jean L. Rouleau, Victor Shi, Ankeet S. Bhatt

المصدر: European journal of heart failure. 23(9)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0158563c12b1a962bcd369756028fa7
https://pubmed.ncbi.nlm.nih.gov/34263507

View record at Wiley

6

Global Differences in Heart Failure With Preserved Ejection Fraction The PARAGON-HF Trial

المساهمون: Cardiovascular Centre (CVC)

المصدر: Circulation-Heart failure, 14(4):007901. LIPPINCOTT WILLIAMS & WILKINS

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::406663cae65e616c3b189648d4f6f30d
https://doi.org/10.1161/circheartfailure.120.007901

7

Cardiac Myosin Activator Omecamtiv Mecarbil Improves Left Ventricular Myocardial Deformation in Chronic Heart Failure: The COSMIC-HF Trial

المؤلفون: Tor Biering-Sørensen, John J.V. McMurray, Masatoshi Minamisawa, Jiankang Liu, G. Michael Felker, Siddique Abbasi, Scott D. Solomon, John R. Teerlink, Fady I. Malik, Brian Claggett, Christopher E. Kurtz

المصدر: Circulation. Heart failure. 13(12)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e8f40b1db047549d9f375d8d904967f
https://pubmed.ncbi.nlm.nih.gov/33176443

8

Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome

المؤلفون: Lars Køber, Scott D. Solomon, Francesca C. Lawson, John J.V. McMurray, Jean-Claude Tardif, Matthew C. Riddle, Jiankang Liu, Hertzel C. Gerstein, Eldrin F. Lewis, Rafael Diaz, Brian Claggett, Jeffrey L. Probstfield, Sung Hee Shin, David Aguilar, Hicham Skali, Marc A. Pfeffer, Aldo P. Maggioni, Kenneth Dickstein

المصدر: Shin, S H, Claggett, B, Pfeffer, M A, Skali, H, Liu, J, Aguilar, D, Diaz, R, Dickstein, K, Gerstein, H C, Køber, L V, Lawson, F C, Lewis, E F, Maggioni, A P, McMurray, J J V, Probstfield, J L, Riddle, M C, Tardif, J C & Solomon, S D 2020, ' Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome ', European Journal of Heart Failure, vol. 22, no. 7, pp. 1133-1143 . https://doi.org/10.1002/ejhf.1790

مصطلحات موضوعية: medicine.medical_specialty, Acute coronary syndrome, Cardiovascular outcomes, Ejection fraction, Type 2 diabetes, 030204 cardiovascular system & hematology, Ventricular Function, Left, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Diabetes mellitus, Internal medicine, medicine, Hyperglycaemia, Humans, cardiovascular diseases, Risk factor, Acute Coronary Syndrome, ejection fraction, Heart Failure, diabetes, business.industry, Hazard ratio, Diabetes, nutritional and metabolic diseases, Stroke Volume, medicine.disease, Prognosis, cardiovascular outcomes, Hospitalization, Diabetes Mellitus, Type 2, Heart failure, Hyperglycemia, Cohort, Cardiology, cardiovascular system, Cardiology and Cardiovascular Medicine, business, hyperglycaemia, circulatory and respiratory physiology